イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

leo pharma a/s - calcipotriolo, associazioni - calcipotriolo, associazioni

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

leo pharma a/s - betametasone e antibiotici - betametasone e antibiotici

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

leo pharma a/s -

欧州連合 - イタリア語 - EMA (European Medicines Agency)

leo pharma a/s - tacrolimus - dermatite, atopica - altri preparati dermatologici - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. che si verificano quattro o più volte all'anno), che hanno avuto una prima risposta a un massimo di sei settimane, il trattamento di tacrolimus unguento due volte al giorno (lesioni cancellato, quasi cancellato o moderatamente influenzato).

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd. - natrii fusidas - salve - natrii fusidas 20 mg, alcohol cetylicus 4 mg, adeps lanae 46 mg, paraffinum liquidum, vaselinum album, e 307, e 321 max. 9.2 µg, ad unguentum pro 1 g. - batteriche infezioni cutanee - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd. - natrii fusidas - compresse rivestite con film - natrii fusidas 250 mg corresp. natrium 10.7 mg, cellulosum microcristallinum, lactosum monohydricum 71.9 mg, crospovidonum, talcum, magnesii stearas, silica colloidalis anhydrica, e 307, Überzug: hypromellosum, e 171 pro compresso obducto. - malattie infettive - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd - natrii fusidas - lo sguardo - tela cum unguento 1.5 g/dm², natrii fusidas 20 mg, adeps lanae 46 mg, alcohol cetylicus 4 mg, vaselinum album, paraffinum liquidum, e 307, e 321 max. 9.2 µg, ad unguentum pro 1 g. - batteriche infezioni cutanee - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - menthae piperitae aetheroleum, camphorae soluzione oleosa - salve - menthae piperitae aetheroleum 2 mg, camphorae soluzione oleosa 4 mg, vaselinum album, paraffinum liquida, grasso con 40 mg e alcol cetylicus e stearylicus 16 mg, propylis parahydroxybenzoas 2 mg, e-218 2 mg e 320 0,1 mg, acqua q.s. il profumo per 1 g. - in caso di secchezza della mucosa nasale - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd. - isoconazoli nitras, diflucortoloni valeras - crema - isoconazoli nitras 10 mg, diflucortoloni valeras 1 mg, polysorbatum 60, sorbitani stearas, alcol cetylicus e stearylicus 50 mg, paraffinum liquido, vaselinum album, dinatrii edetas, acqua di profumo per 1 g. - hautmykosen - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd - hydrocortisoni-17 butyras - lipocreme - hydrocortisoni-17 butyras 1 mg, conserv.: propylis parahydroxybenzoas, alcol benzylicus, excipiens annuncio unguento per 1 g. - malattie della pelle ekzematöser, infiammatoria o allergica genesi - synthetika